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SPECIAL ARTICLE

Critical Care Transesophageal
Echocardiography in Patients during the
COVID-19 Pandemic
Felipe Teran, MD, Katharine M. Burns, MD, Mangala Narasimhan, DO, Alberto Goffi, MD, Paul Mohabir, MD,
James M. Horowitz, MD, Eugene Yuriditsky, MD, Arun Nagdev, MD, Nova Panebianco, MD, MPH,
Eric J. Chin, MD, MBA, Michael Gottlieb, MD, Seth Koenig, MD, and Robert Arntfield, MD, Philadelphia,
Pennsylvania; Oak Lawn and Chicago, Illinois; New Hyde Park, New York, and Bronx, New York; Toronto and
London, Ontario, Canada; Stanford and Oakland, California; Fort Sam Houston, Texas

Background: The COVID-19 pandemic has placed an extraordinary strain on healthcare systems across North
America. Defining the optimal approach for managing a critically ill COVID-19 patient is rapidly changing. Goaldirected transesophageal echocardiography (TEE) is frequently used by physicians caring for intubated critically ill patients as a reliable imaging modality that is well suited to answer questions at bedside.
Methods: A multidisciplinary (intensive care, critical care cardiology, and emergency medicine) group of
experts in point-of-care echocardiography and TEE from the United States and Canada convened to review
the available evidence, share experiences, and produce a consensus statement aiming to provide clinicians
with a framework to maximize the safety of patients and healthcare providers when considering focused
point-of-care TEE in critically ill patients during the COVID-19 pandemic.
Results: Although transthoracic echocardiography can provide the information needed in most patients, there
are specific scenarios in which TEE represents the modality of choice. TEE provides acute care clinicians with
a goal-directed framework to guide clinical care and represents an ideal modality to evaluate hemodynamic
instability during prone ventilation, perform serial evaluations of the lungs, support cardiac arrest resuscitation,
and guide veno-venous ECMO cannulation. To aid other clinicians in performing TEE during the COVID-19
pandemic, we describe a set of principles and practical aspects for performing examinations with a focus
on the logistics, personnel, and equipment required before, during, and after an examination.
Conclusions: In the right clinical scenario, TEE is a tool that can provide the information needed to deliver the
best and safest possible care for the critically ill patients. (J Am Soc Echocardiogr 2020;33:1040-7.)
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SVC = Superior vena cava
critical illness, including shock,
TEE = Transesophageal
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patients with COVID-19 reechocardiography
mains largely supportive. Pointof-care cardiopulmonary ultrasound is a fundamental tool in the evaluation of shock and respiratory
failure10,11 and has been proposed as an ideal diagnostic modality for
patients with COVID-19.12 Although in most patients, transthoracic
echocardiography (TTE) can provide the information needed, there
are situations in which goal-directed transesophageal echocardiography (TEE) provides superior diagnostic value. In contrast to comprehensive echocardiography, TEE provides acute care clinicians with a
goal-directed framework to guide clinical care at the point of care
in various clinical scenarios. Common applications of TEE in critically
ill patients include assessment of circulatory failure, hemodynamic
monitoring, evaluation of unexplained hypoxemia, and cardiac arrest.13-15 Early data suggest that SARS-CoV-2 is associated with multiple cardiovascular complications, including myocardial dysfunction
as well as the presence of a hypercoagulable state, leading to an
increased risk for venous thromboembolic events such as pulmonary
embolism (PE).16-18 Although TEE can offer valuable information in
the assessment and management of patients with these
complications, this modality may carry a heightened risk for viral
transmission and should be therefore considered carefully.
The American Society of Echocardiography has published a
supplemental consensus statement specifically regarding the use of
TEE in the perioperative setting during the COVID-19 pandemic.19
This comprehensive statement provides guidance regarding examination indications, practice protocols, and recommendations for
maintaining the safety of clinicians and equipment. The authors
emphasize the risk for viral transmission during this procedure and
conclude that the benefits must be weighed against the risks.
Despite these guidelines, there remains a lack of published guidance
for acute care physicians trained in critical care TEE. Unlike the
diagnostic work flow, the work flow of the point-of-care echocardiographer is driven entirely by urgent or emergent questions to be
answered in real time. We hope our report addresses this information

gap, as we use this opportunity to discuss the particularities of critical
care TEE during COVID-19.
As a multidisciplinary group of experts in point-of-care echocardiography from the United States and Canada, we convened to review
the available evidence, share experiences, and produce a consensus
statement aiming to provide clinicians with a framework to maximize
the safety of patients and health care providers when considering
point-of-care TEE in critically ill patients during the COVID-19
pandemic. We reflect on specific clinical scenarios clinicians across
care settings may encounter during this pandemic and discuss strategies for managing patient care. The aim of this article is to inform
physicians working in critical care environments who are already
trained and competent users of TEE. It is not meant to be a comprehensive review of the use of TEE in critically ill patients but rather a
practical framework that can be used by clinicians who are competent
in this modality during the management of critically ill patients with
COVID-19. This article is not a call to action among acute care
physicians to use TEE during the pandemic but rather an effort to
assert the ongoing value of this procedure during these times.
Our recommendations focus on principles and practical aspects for
clinicians performing examinations during COVID-19, including
logistics, personnel, equipment preparation, and safe handling before,
during, and after an examination. This article reflects our opinions and
has not been commissioned by any professional society.

GENERAL CONSIDERATIONS FOR TEE IN CRITICALLY ILL
PATIENTS
When considering TEE in critically ill patients it is important to note
the uniqueness of this population, which requires specific discussion
beyond recently published American Society of Echocardiography
guidelines for imaging in patients with COVID-19.12 Frequently
during the initial evaluation of critically ill patients in the emergency
department and intensive care settings, clinical and historical data
are limited. In these settings, TEE is performed exclusively on
intubated patients when transthoracic echocardiographic images are
inadequate or cannot provide needed clinical data. Imaging in this
patient population is time sensitive, never elective, and always goal
directed to provide information that will influence immediate clinical
decision-making.
Given the need for scientific information to guide the safety of
clinical practice in this unprecedented situation and the scarcity of
procedure-specific data pertaining to the risk for viral transmission
with TEE, it makes sense to consider the data available in other similar
endoscopic procedures, as some of the same safety principles can be
used. Numerous gastroenterology and endoscopy societies have
published position statements regarding endoscopic examinations
during the COVID-19 pandemic,20,21 with upper gastrointestinal
endoscopy considered a procedure with a high risk for viral transmission. General recommendations include donning appropriate
personal protective equipment, including an N-95 respirator or a
powered air-purifying respiratory device and a fluid-resistant gown,
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HIGHLIGHTS
 TEE as an invaluable tool for managing the critically ill patient
with COVID-19.
 TEE can be useful when adequate TTE windows cannot be obtained.
 TEE can be useful to address hemodynamic instability during
prone ventilation.
 TEE allows to perform serial evaluations of the lungs.
 TEE is useful to guide critical care procedures such veno-venous
ECMO cannulation.

limiting staff presence in procedure areas, and assigning senior
personnel to perform examinations.22
Aerosolization risks are highest during endoscopy of nonintubated
patients. Because TEE is being performed only in intubated patients,
the risk is assumed to be much lower. Contact and droplet transmission of the virus remains a concern, given the close physical proximity
of patient and provider at the head of the bed. Blood and bodily fluid
splash events can occur,23 and secretions from the endotracheal tube
and transesophageal probe may be transferred from the provider’s
hands to local surfaces. For this reason, appropriate personal protective equipment is a priority when performing TEE.
In contrast with comprehensive TEE, goal-directed TEE during
resuscitation is performed by a single provider who executes all
aspects of the examination, including probe insertion, manipulation,
image acquisition, and probe removal. This provider is often the
same physician who completed the endotracheal intubation (e.g.,
an emergency or intensive care physician), thus limiting provider
and staff exposure.

CONSIDERATIONS IN SPECIFIC APPLICATIONS OF GOALDIRECTED TEE
Cardiac Arrest and Periarrest
Cardiac arrest resuscitation represents a particular challenge in patients with suspected or confirmed COVID-19. Current resuscitation
guidelines emphasize the importance of delivering high-quality chest
compressions and minimizing interruptions to improve survival and
neurological outcomes.24,25 However, in the context of the current
pandemic, the International Liaison Committee on Resuscitation
has provided specific recommendations regarding the infection risk
to providers delivering resuscitation and stated the need to carefully
balance the benefit of resuscitation interventions with the potential
harm from infection to providers.26
TEE has been described as an ideal imaging modality in the
management of patients with cardiac arrest. In addition to the same
diagnostic and prognostic role provided by TTE (e.g., identification
of reversible causes such as cardiac tamponade or PE), TEE also
provides several unique advantages that should be considered.
During resuscitation, TEE has the potential to optimize the quality
of chest compressions by identifying compression of the left ventricular outflow tract,15,27 shorten chest compression interruptions,28
and guide resuscitative procedures such as extracorporeal membrane
oxygenation (ECMO).29,30
In the case of patients with suspected or confirmed COVID-19,
clinicians should carefully consider the potential benefits of this
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procedure against the risks, specifically to health care providers. The
World Health Organization has listed cardiopulmonary resuscitation
as an aerosol-generating procedure (AGP). Additionally, endotracheal intubation is a known AGP, and COVID-19 viral particles
have been shown to remain viable and infectious for multiple hours
in aerosolized form.31 In response, the International Liaison
Committee on Resuscitation has advised that providers use personal
protective equipment for any AGP during cardiac arrest resuscitation.32 One beneficial aspect of TEE during cardiac arrest is that
the transesophageal probe can be left in place throughout the
resuscitation, displaying a continuous image of the heart, as opposed
to TTE, which requires the provider to remain at the bedside for
constant manipulation of the transducer. Figure 1 (see also
Supplemental Videos 1 and 2) shows transesophageal echocardiographic images from a goal-directed examination performed by the
emergency physician during resuscitation of a patient with COVID19 who presented in cardiac arrest and was found to have a right atrial
thrombus and right ventricular dilation consistent with massive PE as
likely cause of the arrest.
Evaluation of Shock and Hemodynamic Monitoring
A significant proportion of patients with COVID-19 may develop
shock and multiorgan failure.1,5 Because there are several shock
etiologies in this patient population, it is essential to characterize the
primary mechanism of shock, and ultrasound is a key tool to accomplish this goal. Although TTE remains the first-line modality for this
assessment in the emergency and intensive care settings, TEE offers
a reliable, safe, and powerful alternative for patients in whom
transthoracic echocardiographic windows are inadequate or unavailable. In patients with COVID-19 in particular, the high-compliance
breathing commonly seen in these patients represents in our experience an additional complicating factor limiting the success acquiring
cardiac windows with TTE.
Furthermore, TEE provides an ideal imaging modality to perform
serial assessments that are often required in patients with shock or
during acute circulatory failure, as it shares most of the properties
of an ‘‘ideal’’ hemodynamic monitoring system.33 That is, the
indwelling nature of the transducer affords a passive, continuous
image for the clinician at the bedside, evaluating anatomic and/or
Doppler responses to various hemodynamic interventions.
Specific applications of TEE in the management of critically ill
patients include the identification of shock etiology,34 determination
of preload sensitivity, and monitoring of hemodynamic interventions.14 The evaluation of patients in shock with TEE has been well
described elsewhere, and although it is not necessarily different in
the context of patients with COVID-19, there are a few considerations worth noting. On the basis of our experience and in line
with the wide spectrum of practice and scalability of critical care echocardiography, the scope of TEE in these patients varies depending on
operator skill set and the clinical question(s) at hand. Common applications for which we have used TEE while managing critically ill
patients with COVID-19 include characterizing the predominant
mechanism of shock, evaluating preload sensitivity using respirophasic variation of superior vena cava (SVC) diameter, and estimating
stroke volume and stroke volume variation to assess the effectiveness
of interventions (e.g., initiating or titrating vasopressor therapy).
Severe acute respiratory syndrome associated with COVID-19
infection has been found to be more severe in those with obesity,1,5
which is precisely the population of patients in whom adequate
transthoracic echocardiography images are often limited. patients
with COVID-19 in the intensive care unit (ICU) are frequently deeply
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Figure 1 TEE during cardiac arrest resuscitation in a patient with COVID-19. Right atrial thrombus (asterisk) visualized in an off-axis
bicaval (A) and a midesophageal four-chamber (B) view, both obtained during ongoing cardiopulmonary resuscitation (CPR). Another
midesophageal four-chamber view (C) of same patient shows a dilated right ventricle (RV) and septal deviation during CPR pause,
suggesting pulmonary embolism. LA, Left atrium; LV, left ventricle; RA, right atrium.

sedated and paralyzed as part of their ventilation needs.
Consequently, the anesthetic considerations with regard to both the
consumption of medications in the pandemic as well as the risk of
these medications are obviated during the decision-making process
to perform TEE.
With respect to the cardiac particularities of COVID-19, an acute
COVID-19 cardiovascular syndrome has been reported in some
hospitalized patients. This syndrome can manifest with a variety of
clinical presentations that include an acute cardiac injury with
cardiomyopathy, ventricular arrhythmias, and hemodynamic
instability in the absence of obstructive coronary artery disease.35
Despite the great amount of literature speculating on cardiac features
of this disease, our experience working in the frontline acute care
settings caring for patients with shock and COVID-19 most
commonly unveils echocardiographic findings we typically see in
other infectious causes of respiratory failure. Namely, these patients
are frequently hyperdynamic and have elevated cardiac output. As
well as in pre-COVID-19 era descriptions of ARDS,36 right ventricular dilation is seen commonly, especially in those who have been
ventilated for $1 week, in whom lung compliance changes, leading
to increased right heart afterload.
Procedural Guidance
Aside from its powerful value as a diagnostic and hemodynamic
monitoring tool, point-of-care TEE also plays a key role during several
critical care procedures. In our experience and as extensively
described in the literature, echocardiographic assistance is commonly
used in a number of emergency procedures, such as initiation and
monitoring of ECMO,37 assistance in placement of pulmonary artery
catheters,38 placement of intravenous pacemaker wires,39 placement
of intra-aortic balloon counterpulsation,40,41 and during catheterdirected thrombolytic therapy.42

Recent international guidelines recommend consideration of
ECMO in patients with severe respiratory failure from SARSCoV-2 infection when conventional management fails, if resources
and expertise are available.43 As of April 25, 2020, 563 patients
with confirmed or suspected COVID-19 have undergone initiation of ECMO and are reported in the Extracorporeal Life
Support Organization registry.44 Goal-directed TEE plays an
important role in the management of these critically ill patients.37
Before initiating venovenous ECMO support in patients with refractory hypoxemia, an echocardiographic assessment should be
performed. Echocardiography may identify unexpected and
reversible findings (e.g., cardiac tamponade, PE) or demonstrate
severe left ventricular dysfunction, which should prompt consideration of venoarterial ECMO. Severe valvular pathology affecting
the success of venovenous or venoarterial ECMO should also
be excluded (e.g., severe aortic insufficiency, mitral regurgitation,
tricuspid stenosis). Although not relevant for cannulation and
ECMO management, detection of patent foramen ovale may
affect weaning consideration. Vascular assessment is essential to
exclude preexisting complications, such as thrombosis, stenosis,
or dissection, and for appropriate selection of type and size of
cannulas.37,45 Normal variants or embryologic remnants of right
heart structures might also affect the appropriate and safe placement of venous cannulas. For example, a prominent Chiari
network may impede proper cannula positioning and increase
the thrombotic risk. A dilated coronary sinus, as observed in
persistent left SVC, may be accidentally cannulated and compromise oxygenation. The presence of pacemaker or defibrillator
leads should also be documented.45
During the cannulation process, TEE allows the evaluation of
proper guidewire and cannula positioning at the bedside in the
ICU. Transesophageal echocardiographic guidance confirms the
course of the guidewire to exclude coiling in the right atrium,
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Figure 2 TELUS of patients with hypoxemia in the intensive care unit (A,B) and emergency department (C,D). (A) Sagittal plane view
of the left lung shows B-lines (asterisk) suggesting increased extravascular lung water. Panels (B) and (C) correspond to sagittal-plane
views of the right costophrenic angle showing consolidation pattern (asterisk) suggestive of atelectasis versus pneumonia. In (D), an
axial-plane view of the left lung shows an atelectatic lung (left asterisk) and pleural effusion (right asterisk). DTA, Descending thoracic
aorta.
displacement across the tricuspid valve, crossing the interatrial
septum, or entering the carotid sinus.45-47 Transesophageal
echocardiographic guidance can ensure that the return cannula is
positioned clear of the tricuspid valve or interatrial septum,
ensuring that the access and return cannulas are placed with
sufficient distance between them to decrease the risk for
recirculation. A dual-lumen bicaval cannula may be used and is placed
in the right internal jugular traversing from the SVC to inferior vena
cava along the posterior aspect of the right atrium.46-48
Following cannulation and during support with ECMO, TEE may
be required to exclude complications related to venovenous
ECMO, as TTE is more limited in its spatial resolution. Such complications include cannula thrombosis, chamber compression from tamponade, or cannula displacement.37,45,46 During this period TEE can
also be used to troubleshoot the development of hypoxemia,
including the identification of recirculation, when the tips of the
cannulae are located too close together, inadequate ECMO flows
due to hypovolemia, and thrombus formation within the cannula.37

a relatively posterior location compared with transthoracic lung ultrasound technique, is its effectiveness at visualizing the more dependent
regions of the lung. These regions are typically very difficult to
visualize in a supine critically ill patient using a surface approach
yet, if densely occupied with alveolar disease or atelectasis (manifest
as consolidation pattern), may contribute to life-threatening respiratory failure. Furthermore, just as with TEE, TELUS affords lung imaging in those with difficult transthoracic windows: obese patients, those
with surgical dressings, and those with subcutaneous emphysema in
particular. Although recruitment maneuvers to open a collapsed
lung are not routinely recommended in patients with ARDS,50 in
our practice targeted recruitment maneuvers still have a role, specifically when atelectatic or consolidated lung is identified. Although it
should be noted that the artifacts that form the basis of lung ultrasonography have not been validated in TEE but rather extrapolated
from transthoracic ultrasound,49 the use TELUS in some of these
selected cases has allowed us to have immediate and real-time feedback on recruitability of the lung. Figure 2 shows examples of TELUS
examinations performed by the intensivist during the evaluation of
patients with hypoxemia in the ICU during the COVID-19 pandemic.

TRANSESOPHAGEAL LUNG ULTRASOUND
With increasing use of both TEE in the resuscitative setting as well as
lung ultrasound, it has become apparent that these approaches may
be effectively combined. In particular, the use of TEE to image the
lungs, so-called transesophageal lung ultrasound (TELUS), has been
increasingly used in the ICU environment after being initially
described in the operative environment.49 This application is rarely
if ever indicated on its own in the critical care environment but rather
as an extension of the TEE examination providing a complete cardiopulmonary assessment, hence increasing the value of this modality.
One of the benefits of imaging the lungs from within the esophagus,

USE OF TEE IN PRONE PATIENTS
Prone positioning ventilation is known to improve ventilationperfusion matching and dorsal alveolar recruitment and has been
associated with improved survival in some patients with ARDS.51
Recent international guidelines for the management of critically ill
patients with COVID-19 have recommended the use of prone
ventilation for 12 to 16 hours in mechanically ventilated adults with
moderate to severe ARDS.52 A distinguishing advantage of TEE is
that it is well suited to be performed in patients during prone
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Table 1 Summary of recommendations for clinicians
performing goal-directed TEE during the COVID-19
pandemic
Preparation (before procedure)
 Perform team huddle outside the room to discuss the indication
and goals, define roles, and address specific actions to take in
order to maximize safety of providers.
 Don full PPE (e.g., gown, gloves, N-95 respirator, face shield). If
possible, we recommend using a PAPR, but it is not required.
 All nonessential equipment should be removed from the
ultrasound system (disconnect and remove all other ultrasound
probes, supplies from the back of the cart, etc.) to reduce the
necessary cleaning and disinfection after the procedure.

Figure 3 Performance of point-of-care TEE with patient in the
prone position.
ventilation.53,54 We have performed TEE on prone patients on several
occasions. The indication is usually that the patient is too hypoxemic
and unstable to unprone. There is usually an urgent need for TEE to
evaluate left ventricular function, for instance, when titrating up positive end-expiratory pressure or when there is concern about the size
and function of the right ventricle to tolerate recruitment maneuvers
when there is evidence of atelectasis. This is also the case as part of the
evaluation for ECMO in patients who remain hypoxemic in prone
ventilation, and the decision for venovenous or venoarterial ECMO
is being considered. The logistical concern is obvious, but the real issue
is only with the actual insertion of the probe into the esophagus; once
that is achieved, the rest of the examination is the same as the usual
transesophageal echocardiographic examination. To successfully
accomplish transesophageal probe insertion on a prone patient, we
have found helpful to turn the patient partially on his or her side
and introduce the probe while maintaining alignment of the head
and chest. The patient is then returned to the prone position, with
the exception of the head and neck, which will remain facing the
examiner while the probe is in place. In our group’s experience, it is
fairly easy to perform TEE in these patients with the proper technique,
as they can remain prone throughout the course of the examination.
We have found that TEE in prone patients has been particularly helpful during the COVID-19 pandemic, given the degree of hypoxemia
seen in these patients and the many urgent ECMO evaluations we
have had to perform. With that said, it should be noted that TEE
will always be easier in the supine position and should therefore be
performed in the prone position only when the information required
is needed urgently enough, as in the situations just described, that the
examination cannot wait until the patient is back to the supine position. Figure 3 shows two of the authors performing a point-of-care
transesophageal echocardiographic examination during hemodynamic decompensation of a patient in prone ventilation.

PRINCIPLES RECOMMENDED FOR CLINICIANS
PERFORMING GOAL-DIRECTED TEE DURING COVID-19
On the basis of the available evidence and our group’s multiinstitutional and interdisciplinary collective experience working in
the frontlines of the pandemic, we have generated a set of principles
and practical aspects for clinicians performing examinations during

During the procedure
 If available, perform TEE in an AIIR (‘‘negative pressure room’’) to
minimize the risk for viral transmission.
 If TEE cannot be performed in an AIIR, we recommend that
providers neither enter nor leave the room for the duration of the
procedure.
 Minimize exposure by limiting the time in the room performing a
goal-directed examination and recording images and loops for
review after the examination is completed.
 During manipulation of the transesophageal probe, be particularly
mindful to avoid inadvertently shifting or disconnecting the
endotracheal tube or accidentally extubating the patient (risk for
aerosolization of viral particles).
After the procedure
 Remove and gently clean the probe to prepare it for transport. Use
a damp cloth to remove any excess secretions on the transducer
after disconnecting from machine. Place the probe in a double
plastic bag or closed container before opening the room.
 Perform first cleaning while in the room. Remove outer gloves if
using double gloves. Using an approved cleansing product, wipe
down inner gloves and touchable parts of the ultrasound system.
 Avoid contamination of the ultrasound system by not touching
surfaces such as the keyboard and screen.
 Perform second cleaning after doffing supplies and exiting the
room (in induction room or anteroom).
 Transport the probe in closed container for processing.
AIIR, Airborne infection isolation room; PAPR, powered air-purifying
respirator.

COVID-19 with focus on the logistics, personnel, and equipment
before, during, and after an examination. These practical recommendations are summarized in Table 1. We recommend that the use of
TEE in this setting be planned at the system level rather than the
provider or department level, with a multidisciplinary approach that
involves not only those performing the studies at the bedside but
also those involved in all related tasks necessary for the examinations
to be performed (e.g., central processing department, transport, technicians). Similar to other high-risk procedures performed routinely
(e.g., endotracheal intubation), we also recommend that clinical teams
have preestablished protocols in place and consider the use of in situ
simulation to familiarize pertinent staff with the steps needed to maximize safety during this procedure. Additionally, to minimize risk during the procedure, the length should be limited to the minimum
required to acquire the images needed in the goal-directed examination. During the examination, images and loops should be recorded
and stored for further review after the examination is completed.
We are aware that the echocardiographic evaluation of dynamic
hemodynamic parameters such as respirophasic variation of the
SVC and velocity-time integral has not been validated in patients
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with ARDS in the context of COVID-19. Nevertheless, on the basis of
our experience, if these are required as part of the goals of TEE, we
recommend that the patient be paralyzed for a short duration to
optimize the conditions of the examination and the reliability of these
parameters. Although providers should be aware of the potential
hazards associated with paralysis and deep sedation, in the context
of COVID-19 infection, paralytics given before insertion of the transesophageal probe have the potential minimize the chance of viral
aerosolization if the intubated patient gags or moves.
Similar to other endoscopic devices, high-level disinfection must be
performed on all transesophageal echocardiographic transducers
between each use.55 A hospital-based protocol should be in place
to ensure that transesophageal probes are disinfected in a standard
manner. The ultrasound system must also be cleaned, as emerging
data suggest that SARS-CoV-2 can be present on surfaces for a number of days.31 Clinicians should refer to the current US Environmental
Protection Agency list of recommended cleansing products and wipe
down the entire ultrasound system in between each patient use.56
This includes the ultrasound screen, keyboard, cart, and so on.
SHOULD POINT-OF-CARE TEE BE USED IN CRITICALLY ILL
PATIENTS DURING THE COVID-19 OUTBREAK?
In our group’s opinion, decisions regarding the use of TEE in critically
ill patients should be made by individual clinicians and their hospitals
and/or clinical units, while also considering the factors mentioned
earlier, local resource availability, and experience. Rather than
establishing one-size-fits-all regulations or policies, we recommend
assessing the use of TEE on a case-by-case basis; if TEE is the tool
that can provide the information needed to deliver the best and safest
possible care for the patient for any of the applications described here,
then TEE should be considered.
CONCLUSION
As resources are stretched in a pandemic scenario, the use of procedures and tools that promote efficiency and accuracy must be maximized. As such, despite plausibility as an AGP, our group of experts
from across North America strongly endorses TEE as an invaluable
tool for managing critically ill patients with COVID-19. The value
of TEE in this pandemic is seen in familiar domains, such as patients
in whom adequate transthoracic echocardiographic windows cannot
be generated, as well as specific scenarios that we have encountered
frequently in the context of the COVID-19. This includes the
increased need to address hemodynamic instability during prone
ventilation, to perform serial evaluations of the lungs, during cardiac
arrest resuscitation, and to guide venovenous ECMO cannulation.
SUPPLEMENTARY DATA
Supplementary data related to this article can be found at https://doi.
org/10.1016/j.echo.2020.05.022.
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